End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.9 CNY | +1.92% |
|
+0.48% | +9.53% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.53% | 7.42B | B- | ||
+63.05% | 856B | C+ | ||
+39.42% | 631B | B | ||
-4.78% | 359B | C+ | ||
+17.52% | 325B | B- | ||
+8.43% | 297B | C+ | ||
+14.19% | 244B | B+ | ||
+5.81% | 234B | A+ | ||
+16.77% | 226B | B- | ||
+14.63% | 177B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 000999 Stock
- Ratings China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.